Search

everythinglearnresearchcommunity

for

Search:↓

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Preservative-free latanoprost effectively lowers eye pressure with fewer side effects.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Certain medications can cause serious side effects, so it's important to report them.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib might be used to treat hair loss.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Co-trimoxazole may help treat autoimmune diseases.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.